Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles B Hicks

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Infectious Diseases|March 28, 2003
Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral controlSusan A Sufka, Guido Ferrari, Victoria E Gryszowka, et al.
AIDS Research and Human Retroviruses|July 31, 2012
Acute HIV-1 infection in the Southeastern United States: a cohort studyMehri S McKellar, Anna B Cope, Cynthia L Gay, et al.
AIDS (London, England)|September 24, 2016
Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durabilityCynthia L Gay, Sarah J Willis, Anna B Cope, et al.
AIDS (London, England)|April 14, 2011
Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infectionCynthia L Gay, Ashley J Mayo, Chelu K Mfalila, et al.
Journal of Virology|February 6, 2009
In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadthXiaoying Shen, Robert J Parks, David C Montefiori, et al.
AIDS (London, England)|August 11, 2020
Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infectionCynthia L Gay, Dayna T Neo, Aaron S Devanathan, et al.
AIDS Research and Human Retroviruses|June 22, 2017
Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV InfectionCynthia L Gay, Mark A DeBenedette, Irina Y Tcherepanova, et al.
Journal of Virology|October 19, 2007
Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infectionS Munir Alam, Richard M Scearce, Robert J Parks, et al.
AIDS (London, England)|April 7, 2007
Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis, Jeffrey P Nadler, Daniel S Berger, et al.
Plos Pathogens|May 21, 2010
High Multiplicity Infection by HIV-1 in Men Who Have Sex with MenHui Li, Katharine J Bar, Shuyi Wang, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|March 28, 2003
Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral controlSusan A Sufka, Guido Ferrari, Victoria E Gryszowka, et al.
AIDS Research and Human Retroviruses|July 31, 2012
Acute HIV-1 infection in the Southeastern United States: a cohort studyMehri S McKellar, Anna B Cope, Cynthia L Gay, et al.
AIDS (London, England)|September 24, 2016
Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durabilityCynthia L Gay, Sarah J Willis, Anna B Cope, et al.
AIDS (London, England)|April 14, 2011
Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infectionCynthia L Gay, Ashley J Mayo, Chelu K Mfalila, et al.
Journal of Virology|February 6, 2009
In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadthXiaoying Shen, Robert J Parks, David C Montefiori, et al.
AIDS (London, England)|August 11, 2020
Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infectionCynthia L Gay, Dayna T Neo, Aaron S Devanathan, et al.
AIDS Research and Human Retroviruses|June 22, 2017
Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV InfectionCynthia L Gay, Mark A DeBenedette, Irina Y Tcherepanova, et al.
Journal of Virology|October 19, 2007
Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infectionS Munir Alam, Richard M Scearce, Robert J Parks, et al.
AIDS (London, England)|April 7, 2007
Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis, Jeffrey P Nadler, Daniel S Berger, et al.
Plos Pathogens|May 21, 2010
High Multiplicity Infection by HIV-1 in Men Who Have Sex with MenHui Li, Katharine J Bar, Shuyi Wang, et al.
Pageof 9